Scientists now use advanced techniques to study the human immune system at a single-cell level. They perform single-cell immune profiling in both infectious and autoimmune diseases. Researchers rely on high-dimensional data analysis using CyTOF and scRNA-seq to gain deeper insights.
First, they collect blood or tissue samples from patients. Then, they apply CyTOF (mass cytometry) and single-cell RNA sequencing (scRNA-seq). These technologies allow scientists to examine thousands of individual immune cells simultaneously. Moreover, they measure dozens of proteins and genes in each cell at the same time.
Furthermore, researchers analyze the complex high-dimensional data. They use advanced bioinformatics tools and machine learning algorithms. As a result, they can identify rare immune cell populations and track how these cells change during disease.
In infectious diseases like COVID-19 or tuberculosis, single-cell profiling reveals how immune cells respond to pathogens. Scientists observe excessive inflammation or exhausted T cells. In addition, they can detect early warning signs of severe disease progression.
On the other hand, in autoimmune diseases such as rheumatoid arthritis or lupus, this approach shows abnormal immune activation. Researchers identify overactive B cells and dysregulated T helper cells. Consequently, they understand why the immune system attacks the body’s own tissues.
Moreover, combining CyTOF and scRNA-seq provides a more complete picture. CyTOF gives precise protein expression data, while scRNA-seq reveals gene activity at the transcript level. Therefore, scientists can connect gene expression with actual cell function.
This powerful analysis helps discover new disease biomarkers. It also supports the development of targeted therapies. Furthermore, doctors can use these insights to predict which patients may develop severe complications.
Overall, single-cell immune profiling using CyTOF and scRNA-seq represents a major advancement in immunology. It allows researchers to understand complex immune responses with unprecedented detail. As a result, this technology is transforming how we study and treat both infectious and autoimmune diseases.